BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1495018)

  • 1. Quenched molecular dynamics simulations of tuftsin and proposed cyclic analogues.
    O'Connor SD; Smith PE; al-Obeidi F; Pettitt BM
    J Med Chem; 1992 Jul; 35(15):2870-81. PubMed ID: 1495018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulations of conformers of tuftsin and a cyclic tuftsin analog.
    Valdeavella CV; Blatt HD; Pettitt BM
    Int J Pept Protein Res; 1995 Nov; 46(5):372-80. PubMed ID: 8567181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
    Nishioka K; Obeyesekere NU; McMurray JS
    Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution conformation of tuftsin.
    D'Ursi A; Pegna M; Amodeo P; Molinari H; Verdini A; Zetta L; Temussi PA
    Biochemistry; 1992 Oct; 31(40):9581-6. PubMed ID: 1327119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution conformation of a potent cyclic analogue of tuftsin: low- temperature nuclear magnetic resonance study in a cryoprotective mixture.
    D'Ursi A; Albrizio S; Fattorusso C; Lavecchia A; Zanotti G; Temussi PA
    J Med Chem; 1999 May; 42(10):1705-13. PubMed ID: 10346923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
    Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition between tuftsin and HBV S-protein sequences.
    Siemion IZ; Słoń J; Nawrocka E; Wieczorek Z
    Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
    Mezö G; Szekerke M; Sármay G; Gergely J
    Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.
    Paradowski A; Dynowski Z; Kubik A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):147-52. PubMed ID: 1804045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salt effects on peptide conformers: a dielectric study of tuftsin.
    Yang L; Valdeavella CV; Blatt HD; Pettitt BM
    Biophys J; 1996 Dec; 71(6):3022-9. PubMed ID: 8968573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
    Siemion IZ; Słoń J; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):469-78. PubMed ID: 1841544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
    Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further investigations on the antinociceptive activity of tuftsin analogs.
    Nawrocka-Bolewska E; Kubik A; Szewczuk Z; Siemion IZ; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1991; 43(4):281-8. PubMed ID: 1811220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunomodulatory activity of tetra- and tripeptides of tuftsin-kentsin group.
    Wieczorek Z; Zimecki M; Słoń JJ; Siemion IZ
    Peptides; 1994; 15(2):215-21. PubMed ID: 8008626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydration effects on the electrostatic potential around tuftsin.
    Valdeavella CV; Blatt HD; Yang L; Pettitt BM
    Biopolymers; 1999 Aug; 50(2):133-43. PubMed ID: 10380337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
    Liu ZP; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of conformation on the conversion of cyclo-(1,7)-Gly-Arg-Gly-Asp-Ser-Pro-Asp-Gly-OH to its cyclic imide degradation product.
    Bogdanowich-Knipp SJ; Jois SD; Siahaan TJ
    J Pept Res; 1999 Jul; 54(1):43-53. PubMed ID: 10448969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicry.
    Chaudhuri MK; Konopińska D; Bump NJ; Najjar VA
    Ann N Y Acad Sci; 1983; 419():135-42. PubMed ID: 6324634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of glycosylated tuftsins and tuftsin-containing IgG fragment undecapeptide.
    Biondi L; Filira F; Gobbo M; Scolaro B; Rocchi R
    Int J Pept Protein Res; 1991 Feb; 37(2):112-21. PubMed ID: 2019473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
    Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
    Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.